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DNA titration and viscosity showed that both compound 1 and
2 binds with DNA via intercalation. UV–Vis absorption of
compound 1 and 2 upon addition of CT-DNA change upon
increment of DNA concentration. The intrinsic binding
constant (Kb) of the complexes 1 and 2 are 1.08x103 M-1 and
5.225x103 M-1, respectively. with the CT-DNA.
UV/VIS SPECTRA
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Auxochrome molecule in compound 1 increase the electron density in the π-system. As they lower the excitation π∗-level, a longer wavelength is needed for 
the excitation along π→π∗, hence the λmax value is shifted to a longer wavelength (bathochromic effect)6.
DNA TITRATION VISCOSITY MEASUREMENT
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INTRODUCTION
(2)(1)
Cancer is a gene mutation in the cell that grows uncontrollably. Many drugs have been successfully
developed to treat this disease but could not provide effective solutions for cancer treatment, in which
the major problem of these drugs is their cytotoxicity. The usual cancer treatment tends to kills the
cancerous cell along with healthy cell around it. An alpha,beta- (α,β-) unsaturated ketone at the core of
the chalcone feature provides the basis for the wide range of its biological activities including
anticancer effect and can be prepared via Claisen-Schmidt condensation reaction between
acetophenone and benzaldehydes with base or acid as catalyst1. Pyrrole-chalcones of 3-(2,5-dimethoxy-
phenyl)-1-(1H-pyrrole-3-yl)-propenone (compound 1) and 1-(1H-pyrrol-2-yl)-3-m-tolylpropenone
(compound 2) were screened for anticancer properties through deoxyribonucleic acid (DNA) binding
assay by Ultraviolet Visible (UV/VIS) absorption spectroscopy. The intrinsic binding constant (Kb) of
complexes 1 and 2 with calf-thymus DNA (CT-DNA) are 1.08x103 M-1 and 5.225x103 M-1, respectively. It
was found that compound 1 has a higher binding affinity than compound 2 due to methoxyl (-OCH3)
group is a better electron donating group with an ability to form intramolecular hydrogen bonding with
DNA in comparison to methyl (-CH3) moiety. The UV-Visible titration studies suggest that chalcones
bind to DNA via intercalation mechanism as it induces hyperchromic effect as shown in the λmax
2.
Results obtained from this work would be very useful in understanding the mechanism of interaction of
the Pyrrole-chalcone analogues binding to DNA and serve as preliminary information for the
development as a new potential anticancer agents.
1. Suwito, H. et al. (2014). "Chalcones: synthesis, structure diversity and pharmacological aspects." J.
Chem. Pharm. Res., 6(5):1076-1088.
2. Shahabadi, N. & Mohammadi, S. (2012). "Synthesis characterization and DNA interaction studies
of a new Zn (II) complex containing different dinitrogen aromatic ligands." Bioinorg. Chem. Appl.,
http://dx.doi.org/10.1155/2012/571913.
3. Yadav, VR. et al. (2011). "The role of chalcones in suppression of NF-κB-mediated inflammation
and cancer." Int. Immunopharmacol., 11(3):295-309.
4. Zarate, X. et al. (2016). “Interaction of chalcones wirophotometric analysis and theoretical
simulations." Quím Nova 39(8) (2016):914-918.
5. Zhan, XP. et al. (2017). “Synthesis and Anticancer Activity of 3-(substituted Aryl)-4-(3,4,5-
trimethoxyphenyl)-1H-pyrrole Derivatives.” Chem. Biodiversity, 48(16)1:5140–5153.
6. Kumar, S. (2006). “Spectroscopy of organic compounds.” New Age International Pvt Ltd Publishers,
New Delhi.
• Compound 1 and 2 are novel synthetic Pyrrole-chalcones that have been successfully synthesized
and structurally characterized via IR, NMR and MS.
• A new single crystal of compound 1 was grown by slow evaporation of ethanol.
• The molecular structure, thermal properties and validation of the experimental vibrational spectra
of the new single crystal of compound 1 were studied.
• The experimental and calculated vibrational spectra of the new single crystal of compound 1 were
comparable.
• Substituent on the benzene ring of the synthesized compound affect the electronic properties of
the whole molecules thus affected the DNA binding affinity of these molecules .
• Compound 1 showed higher binding affinity towards CT-DNA with greater DNA binding in
comparison to compound 2 based on the intrinsic binding constant (Kb).
• Presence of methoxyl group in compound 1, helps in improving the bioavailability of the
compound. This is explained by the stabilization effect via resonance of the electron donating
ability of the methoxyl moeity.
• Both compounds binded to the CT-DNA via intercalation mode.
A single crystal of compound 1 was
obtained and successfully
characterized both theoretically and
experimentally, using quantum
chemical calculation, solid-state
Raman and IR spectroscopy and sc
X-ray diffraction.
During cancer process, the genomes of incipient cancer cells acquire mutant alleles of proto-oncogenes,
tumor-suppressor genes, and other genes that control, directly or indirectly, cell proliferation3. The
alternation of cellular DNA could actually stop the tumor spread. Chalcone derivatives structure has
been known as an anticancer agent by binding with target site to stop the tumor cells from spreading.
In addition to its anti-cancerous effect, chalcone derivatives have been targeted to inhibit DNA as the
main target, as DNA does the replication and transcription in cancer cells. The interaction between
DNA and several compounds that affect the replication process and inhibition of the cancer cells is the
basic in designing anticancer drug4. Chalcones effectiveness as anticancer depends on the mode and
affinity of their binding ability to the DNA strands4. The pyrrole show potent anticancer activity where
the electron donating group is attached to pyrrole is believed to increased the anticancer activity5.
Previous studies indicated that chalcone and pyrrole are an interesting substances that have wide
usage and combinations of both scaffolds have attracted many biological interests. Hence, Pyrrole-
chalcone analogues have been synthesized in order to find the DNA binding affinity towards DNA.
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